We are live on
!
Find out more
B
BP Portfolio holdings
AUM
$17.7M
1-Year Est. Return
12.34%
This Fund
S&P 500
This Quarter
Est. Return
+2.37%
1 Year Est. Return
+12.34%
3 Year Est. Return
+57.04%
5 Year Est. Return
+25.97%
10 Year Est. Return
+282.85%
AUM
$3.14B
AUM Growth
-$790M
(-20%)
Cap. Flow
-$826M
Cap. Flow
% of AUM
-26.27%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
331
New
22
Increased
31
Reduced
94
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$9.65M |
| 2 |
Newmont
NEM
|
+$9.35M |
| 3 |
BMS
Bemis
BMS
|
+$9.29M |
| 4 |
Boeing
BA
|
+$9.17M |
| 5 |
Lockheed Martin
LMT
|
+$9.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$574M |
| 2 |
Union Pacific
UNP
|
+$20.9M |
| 3 |
Petrobras
PBR
|
+$12.3M |
| 4 |
Johnson & Johnson
JNJ
|
+$11.7M |
| 5 |
Apple
AAPL
|
+$11.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.68% |
| 2 | Financials | 15.06% |
| 3 | Technology | 11.97% |
| 4 | Consumer Staples | 11.94% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bristol-Myers Squibb
BMY
$129B
| $23.1M | 0.73% |
358,000
| – | – |
|
27
Merck
MRK
$322B
| $23.1M | 0.73% |
420,248
-47,160
| -10% | -$2.67M |
|
28
Intel
INTC
$413B
| $21.9M | 0.7% |
700,000
-79,000
| -10% | -$2.67M |
|
29
Target
TGT
$66.3B
| $21.4M | 0.68% |
261,000
| – | – |
|
30
Amazon
AMZN
$2.44T
| $21.2M | 0.67% |
1,140,000
| – | – |
|
31
Meta Platforms (Facebook)
META
$1.49T
| $21.2M | 0.67% |
258,000
+6,000
| +2% | +$470K |
|
32
Coca-Cola
KO
$383B
| $21.1M | 0.67% |
520,000
-127,000
| -20% | -$5.31M |
|
33
Zoetis
ZTS
$32.7B
| $20.8M | 0.66% |
450,000
+16,000
| +4% | +$721K |
|
34
AT&T
T
$164B
| $20.7M | 0.66% |
840,740
-264,800
| -24% | -$6.73M |
|
35
Itaú Unibanco
ITUB
$89.8B
| $20.6M | 0.66% |
4,653,980
-355,256
| -7% | -$1.73M |
|
36
Visa
V
$701B
| $20.2M | 0.64% |
308,000
| – | – |
|
37
IBM
IBM
$213B
| $20.1M | 0.64% |
130,750
-20,920
| -14% | -$3.17M |
|
|
WWAV
38
DELISTED
The WhiteWave Foods Company
WWAV
| $19.9M | 0.63% |
450,000
| – | – |
|
39
Comcast
CMCSA
$87.3B
| $18.8M | 0.6% |
666,000
| – | – |
|
40
CVS Health
CVS
$135B
| $18.8M | 0.6% |
182,000
| – | – |
|
41
PepsiCo
PEP
$196B
| $18.7M | 0.6% |
196,000
-33,000
| -14% | -$3.19M |
|
42
Honeywell
HON
$76.4B
| $18.5M | 0.59% |
196,982
| – | – |
|
43
Constellation Brands
STZ
$22.5B
| $18.1M | 0.58% |
156,000
+58,000
| +59% | +$6.53M |
|
44
UnitedHealth
UNH
$382B
| $17.9M | 0.57% |
151,000
| – | – |
|
45
Eli Lilly
LLY
$1.08T
| $17.7M | 0.56% |
244,000
| – | – |
|
46
Banco Bradesco
BBD
$37.4B
| $17.6M | 0.56% |
4,026,264
-307,341
| -7% | -$1.51M |
|
47
Philip Morris
PM
$309B
| $17.1M | 0.54% |
227,000
-24,000
| -10% | -$1.95M |
|
48
Oracle
ORCL
$339B
| $16.8M | 0.54% |
390,000
| – | – |
|
49
RTX Corp
RTX
$290B
| $16.5M | 0.53% |
224,049
| – | – |
|
50
Ford
F
$60.9B
| $16.1M | 0.51% |
1,000,000
| – | – |
|
Similar funds
CP
BCPE
AE
SCTC
HIM
MPW
LPC
PA
BP's Q1 2015 Portfolio in Review
As of Q1 2015, BP held 331 positions worth $3.14B, down 20% from $3.93B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
BP withdrew a net $826M in Q1 2015, closing 37 positions and reducing 94 holdings. Its most notable exit was Petrobras, an estimated $12.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 13% a quarter earlier, followed by Financials and Technology.
Against the trend, BP opened a new position in Bemis worth $9.26M.
- BP's largest Q1 2015 buy was Bemis: 200,000 shares worth $9.26M.
- BP added most to Allergan plc in Q1 2015, an estimated $9.65M increase.
- BP's biggest Q1 2015 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $574M.
- BP fully exited Petrobras in Q1 2015, selling an estimated $12.3M.
- BP's ten largest holdings make up 23% of its $3.14B portfolio in Q1 2015.
- BP opened 22 new positions and closed 37 in Q1 2015.
- BP's portfolio value fell 20% quarter-over-quarter to $3.14B.
Based on BP's 13F filing for Q1 2015, filed 1 May 2015.